Independent report: Flu vaccines 2027 to 2028: JCVI advice, 16 July 2026
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about vaccines for the 2027 to 2028 influenza season.
UK, EU & international health agencies
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about vaccines for the 2027 to 2028 influenza season.
Tens of thousands of cancer patients have rated the care they received from the NHS as nearly 9 out of 10, as NHS teams see and treat record numbers of people for the disease. The latest patient experience figures come as NHS cancer checks have reached nearly 3.4 million in a year – more than doubling in the last decade. The number of patients receiving cancer […]
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2025–26 Annual Report and Accounts highlighting a year of strong and consistent delivery as set out in the agency’s first Results and Forecast report earlier this year.
Describes the working relationship between the Department of Health and Social Care and the Human Fertilisation and Embryology Authority.
Guidance on managing risk of bloodborne viruses (BBVs), such as hepatitis B, hepatitis C and HIV, in bomb blast victims.
New negotiating body to be set up as part of the first ever adult social care fair pay agreement, representing millions of care workers.
All babies in England will be screened for spinal muscular atrophy (SMA).
Letter about the pay round for the financial year 2027 to 2028 from the Secretary of State for Health and Social Care to the Review Body on Doctors’ and Dentists’ Remuneration (DDRB).
Letter about the pay round for the financial year 2027 to 2028 from the Secretary of State for Health and Social Care to the NHS Pay Review Body (NHSPRB).
Letter about the pay round for the financial year 2027 to 2028 from the Secretary of State for Health and Social Care to the Senior Salaries Review Body.
The MHRA is strengthening safety warnings for all botulinum toxin type A products, following reports of rare cases of botulism linked to their use.
Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of UK‑donor plasma for five high‑priority plasma-derived medicinal products.
Cases of iatrogenic botulism have been reported following the therapeutic or cosmetic use of botulinum toxin containing products where the toxin’s effect extends beyond the area of treatment. Patients should seek immediate medical advice if they experience signs and symptoms.
Annual report and data tables showing how often bloodstream infections occur in critical care in England, the microbes that cause them, and linked factors.
Details of the organisations that are currently approved to undertake conformity assessments on medical devices.
Guidance on transitional arrangements for the Clinical Trials Regulations.
This plan sets out how the Department of Health and Social Care plans to improve the use of BSL in its communications in the next 5 years. Includes an annual progress update.
EMA and the European Innovation Council and SMEs Executive Agency (EISMEA) have strengthened their cooperation in support of health innovation in the European Union (EU). Today…, Enabling innovation is central to our public health mission to bring new treatments to patients. Our collaboration with EISMEA helps us better support innovators to…, The earlier health innovators can engage with regulatory expertise, the better equipped they are to make informed development decisions, reduce risk and achieve our…, EMA and EISMEA will continue to work together on horizon scanning and regulatory…
Guidance on the collection, verification, and reporting of safety events in clinical trials of an investigational medicinal product.
Families across the country are being encouraged to help children stay active over the summer holidays.
MHRA annual report and accounts 2025 to 2026.
Brussels, 14 July 2026Check against delivery (The published text is based on the prepared speech. Minor differences may have occurred during delivery)Dear Ms Jerkovic, dear…
The Pathogen Genomics Department at Porton Down provides a sequencing service for SARS-CoV-2 for customers across the NHS and UKHSA.
Describes the working relationship between the Department of Health and Social Care and the UK Health Security Agency.